Pfizer’s CEO Albert Bourla hit with 35% pay cut to $21.6M

‘CEO Albert Bourla took a 35% hit in his pay as it fell (PDF) from $33 million in 2022 to $21.6 million last year, according to a regulatory filing.

With the company raking in huge profits during the pandemic years, Bourla ranked No. 2 among industry CEOs in 2021 at $24.3 million and No. 3 in 2022 as he made $33 million. But his compensation last year will likely knock him out of the top 10.’

https://www.fiercepharma.com/pharma/pfizer-struggling-2023-ceo-bourla-sustains-35-pay-cut-216m#:~:text=CEO%20Albert%20Bourla%20took%20a,according%20to%20a%20regulatory%20filing.

Uh-oh! It looks like you're using an ad blocker.

Our website relies on ads and the generous support of readers like you to keep delivering free, high-quality content. Right now, we are facing serious funding challenges and we need your help more than ever. Disable your ad blocker and this message will vanish. You can also sign up for a membership to enjoy an ad-free experience while supporting our work: https://citizenwatchreport.com/plans/subscriptions/ Your support helps us stay independent, continue our work, and keep content free for everyone. We truly appreciate your understanding and thank you for standing with us.